Beximco Group

About

Beximco Pharmaceuticals ​Beximco Pharmaceuticals Limited (widely known as Beximco Pharma) is a pioneering, multinational pharmaceutical company in Bangladesh. Founded in 1976 and commencing operations in 1980, it is a flagship entity of the BEXIMCO Group. What began as an importer and distributor for global MNCs has transformed into a global generic pharma giant, renowned for producing high-quality, affordable medicines and elevating Bangladesh’s pharmaceutical industry on the world stage. ​Products & Offerings ​Beximco Pharma boasts a vast portfolio of over 500 products encompassing almost all major therapeutic categories. Their core offerings include: ​Branded Generics: A massive range of everyday and specialized medicines, including the household staple Napa (Paracetamol), alongside treatments for cardiovascular, central nervous system, respiratory, and dermatological conditions. ​Active Pharmaceutical Ingredients (APIs) & IV Fluids: Manufacturing critical raw materials (APIs) and intravenous fluids to ensure self-reliance in the healthcare supply chain. ​Specialized & Lifesaving Drugs: Recognized globally for rapid innovation, such as introducing the world's first generic versions of Remdesivir and Molnupiravir during the COVID-19 pandemic. ​Contract Manufacturing: Providing high-quality, cost-effective manufacturing services for global pharmaceutical firms. ​Brand Impact & Specialization ​Beximco Pharma’s ultimate specialization is its uncompromising adherence to global regulatory standards. It holds the unique prestige of being the first Bangladeshi pharmaceutical company to export medicines to the highly regulated US market. Its state-of-the-art manufacturing facilities are accredited by the US FDA, TGA (Australia), Health Canada, and the European Union. Furthermore, it is the only Bangladeshi company listed on the Alternative Investment Market (AIM) of the London Stock Exchange. Through massive expansions—including the acquisition of Sanofi Bangladesh (now Synovia Pharma) and Nuvista Pharma—Beximco consistently drives the domestic market forward. ​Portfolio Summary ​Driven by the mission to enhance human health and wellbeing, Beximco Pharma is a beacon of industrial excellence in Bangladesh. By seamlessly merging state-of-the-art technology, relentless research, and a commitment to affordability, it not only secures the healthcare needs of the nation but proudly represents "Made in Bangladesh" in over 50 countries worldwide.